Towards Best Practice for Chronic HIV Care Professor Georg Behrens - - PowerPoint PPT Presentation

towards best practice for chronic hiv care
SMART_READER_LITE
LIVE PREVIEW

Towards Best Practice for Chronic HIV Care Professor Georg Behrens - - PowerPoint PPT Presentation

HIV Outcomes: Beyond viral suppression Towards Best Practice for Chronic HIV Care Professor Georg Behrens Department for Clinical Immunology and Rheumatology Hannover University Hospital, Germany HIV infection today From HIV-patients to


slide-1
SLIDE 1

Towards Best Practice for Chronic HIV Care

Professor Georg Behrens Department for Clinical Immunology and Rheumatology Hannover University Hospital, Germany

HIV Outcomes: Beyond viral suppression

slide-2
SLIDE 2

HIV infection today

From HIV-patients to people living with HIV (PLWH)

slide-3
SLIDE 3

57 Age 59

109,000

CD4 HIV-RNA 55 1082

<20

Burkitt lymphoma

AIDS HIV+ HIV+

My patients from last week…

slide-4
SLIDE 4
  • Mindful & dedicated HIV physician
  • Strong & influencial HIV community

Some key steps were driving the success

  • f HIV therapy (we continue to need them)
slide-5
SLIDE 5
  • Mindful & dedicated HIV physicians
  • Strong & influencial HIV community
  • Science, Science, Science
  • Rapidly developing drug pipeline

Some key steps were driving the success

  • f HIV therapy (we continue to need them)
slide-6
SLIDE 6
  • Mindful & dedicated HIV physicians
  • Strong & influencial HIV community
  • Science, Science, Science
  • Rapidly developing drug pipeline
  • Combination therapy (cART)
  • Individualized therapy (e.g. HLA-B 57:01 Testing)

Some key steps were driving the success

  • f HIV therapy (we continue to need them)
slide-7
SLIDE 7
  • Mindful & dedicated HIV physicians
  • Strong & influencial HIV community
  • Science, Science, Science
  • Rapidly developing drug pipeline
  • Combination therapy (cART)
  • Individualized therapy (e.g. HLA-B 57:01 Testing)
  • Novel technologies (PCR in routine lab)
  • Interdisciplinary work (e.g. resistance testing)

Some key steps were driving the success

  • f HIV therapy (we continue to need them)
slide-8
SLIDE 8
  • Mindful & dedicated HIV physicians
  • Strong & influencial HIV community
  • Science, Science, Science
  • Rapidly developing drug pipeline
  • Combination therapy (cART)
  • Individualized therapy (e.g. HLA-B 57:01 Testing)
  • Novel technologies (PCR in routine lab)
  • Interdisciplinary work (e.g. resistance testing)
  • High quality trials (based on surrogate markers)
  • Successful international cohort studies (Networks)

Some key steps were driving the success

  • f HIV therapy (we continue to need them)
slide-9
SLIDE 9

1st line therapy for HIV patients

Focus on

  • Prevent disease progression
  • Suppress viral replication
  • Prevent resistance mutation development
  • Maintain adherence

Early phase

slide-10
SLIDE 10

Life long therapy for HIV patients

Focus on

  • Long-term toxicity
  • Long-term HIV infection
  • Co-morbidities
  • Ageing

Later phase

slide-11
SLIDE 11

Later phase

25 420

(42%)

<20

HIV+ since birth CD4 HIV-RNA

ART: 2 pills/day!

Life long therapy for HIV patients

Focus on

  • Long-term toxicity
  • Long-term HIV infection
  • Co-morbidities
  • Ageing
slide-12
SLIDE 12

From todays HIV therapy… … to tomorrows HIV medicine! HIV Infection 2.0